TTUHSC Public Health Program Receives Accreditation

MPH

The Texas Tech University Health Sciences Center (TTUHSC) Masters of Public Health (MPH) program received accreditation from the Council on Education for Public Health.  Theresa Byrd, DrPH, associate dean and chair of the TTUHSC Julia Jones Matthews Department of Public Health, said the program now is accredited until 2023.


“We are really excited,” Byrd said. “This was a lot of work, and several of the faculty really dedicated themselves to making this happen. Our next step is to develop our first doctoral program, which we hope to have approved and ready to accept students in 2020.” 


Located on the Lubbock and Abilene campuses and administered by the Graduate School of Biomedical Sciences, the Julia Jones Matthews Department of Public Health offers the MPH degree program both face-to-face and online. In addition, the department offers an online certificate in public health.


The training emphasizes public health competencies and the integration and application of those competencies to public health practice. The MPH provides students with the knowledge, skills and values needed to succeed in public health careers. The department also has two dual degree programs, M.D./MPH and MPA/MPH (in approval stages) and is developing others. There have been 56 graduates from the program, including 38 MPH students and 18 M.D./MPH students.


“We are proud of our students and we know they will accomplish great things,” Byrd said. “We also are grateful for our supportive administration, especially President Tedd Mitchell who has been committed to getting public health programs at TTUHSC, and Dr. Brandt Schneider, dean of the Graduate School of Biomedical Sciences, who worked closely with us during the process.”


The Council on Education for Public Health is the nationally recognized accrediting body for schools of public health and public health programs. The TTUHSC MPH program is the first school or program to undergo the accreditation process under the council’s newly revised guidelines.

 

MPH

A submission for approval for the establishment of the TTUHSC MPH program was made to the Texas Higher Education Coordinating Board and approved October 24, 2013. The first MPH class began in September 2014.


For more information about the TTUHSC MPH program, visit http://www.ttuhsc.edu/gsbs/publichealth/default.aspx.

 

Related Stories

Celebrating Veterans: TTUHSC’s General Martin Clay’s Legacy of Service and Leadership

From his initial enlistment in the Army National Guard 36 years ago to his leadership in military and civilian health care management roles, Major General Martin Clay’s career has been shaped by adaptability, mission focus and service to others.

Texas Tech University Health Sciences Center School of Nursing Named Best Accelerated Bachelor of Science in Nursing Program in Texas

The TTUHSC School of Nursing Accelerated Bachelor of Science in Nursing (BSN) program has been ranked the No. 1 accelerated nursing program in Texas by RegisteredNursing.org.

TTUHSC Names New Regional Dean for the School of Nursing

Louise Rice, DNP, RN, has been named regional dean of the TTUHSC School of Nursing on the Amarillo campus.

Recent Stories

Research

Abid Brings Hematology Expertise to TTUHSC Oncology Team

Muhammad Bilal Abid, M.D., has joined the TTUHSC School of Medicine oncology team as an associate professor of internal medicine and medical director of TTUHSC’s Blood and Marrow Transplantation & Cellular Therapy Program.

Research

Research Team Studies Cardiovascular Disease Risk in Homeless Population

A team of student researchers from TTUHSC and TTU evaluated differences in CVD risk between men and women experiencing poverty and homelessness in West Texas, a medically underserved region within the TTUHSC service area.

Research

Clinical Trials Provide Access to Latest Cancer Interventions

Beginning in 2008, TTUHSC, through the School of Medicine Pediatric Cancer Research Center in 2025, has conducted multiple phase 1 oncology clinical trials for pediatric and adult cancer patients. These trials will pave new ground for patients now and in the future.